PRNewsWire - Health

Biolexis Therapeutics Advances Breakthrough GLP-1 and AMPK Programs into First-in-Human Clinical Trials
CareRev Expands On-Demand Workforce Platform, Now Supports Allied & Ancillary Healthcare Professionals
Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group